Literature DB >> 22465472

Inhalation of sulfur mustard causes long-term T cell-dependent inflammation: possible role of Th17 cells in chronic lung pathology.

Neerad C Mishra1, Jules Rir-sima-ah, Gary R Grotendorst, Raymond J Langley, Shashi P Singh, Sravanthi Gundavarapu, Waylon M Weber, Juan C Pena-Philippides, Matthew R Duncan, Mohan L Sopori.   

Abstract

Sulfur mustard (SM) is a highly toxic chemical warfare agent that remains a threat to human health. The immediate symptoms of pulmonary distress may develop into chronic lung injury characterized by progressive lung fibrosis, the major cause of morbidity among the surviving SM victims. Although SM has been intensely investigated, little is known about the mechanism(s) by which SM induces chronic lung pathology. Increasing evidence suggests that IL-17(+) cells are critical in fibrosis, including lung fibrotic diseases. In this study we exposed F344 rats and cynomolgus monkeys to SM via inhalation and determined the molecular and cellular milieu in their lungs at various times after SM exposure. In rats, SM induced a burst of pro-inflammatory cytokines/chemokines within 72 h, including IL-1β, TNF-α, IL-2, IL-6, CCL2, CCL3, CCL11, and CXCL1 that was associated with neutrophilic infiltration into the lung. At 2 wks and beyond (chronic phase), lymphocytic infiltration and continued elevated expression of cytokines/chemokines were sustained. TGF-β, which was undetectable in the acute phase, was strongly upregulated in the chronic phase; these conditions persisted until the animals were sacrificed. The chronic phase was also associated with myofibroblast proliferation, collagen deposition, and presence of IL-17(+) cells. At ≥30 days, SM inhalation promoted the accumulation of IL-17(+) cells in the inflamed areas of monkey lungs. Thus, SM inhalation causes acute and chronic inflammatory responses; the latter is characterized by the presence of TGF-β, fibrosis, and IL-17(+) cells in the lung. IL-17(+) cells likely play an important role in the pathogenesis of SM-induced lung injury.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22465472      PMCID: PMC3340497          DOI: 10.1016/j.intimp.2012.03.010

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  67 in total

Review 1.  Chemoattractants as mediators of neutrophilic tissue recruitment.

Authors:  J M Schröder
Journal:  Clin Dermatol       Date:  2000 May-Jun       Impact factor: 3.541

2.  TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P.

Authors:  Lynne A Murray; Qingsheng Chen; Michael S Kramer; David P Hesson; Rochelle L Argentieri; Xueyang Peng; Mridu Gulati; Robert J Homer; Thomas Russell; Nico van Rooijen; Jack A Elias; Cory M Hogaboam; Erica L Herzog
Journal:  Int J Biochem Cell Biol       Date:  2010-10-29       Impact factor: 5.085

3.  Apoptotic activity is increased in the newly formed fibromyxoid connective tissue in bronchiolitis obliterans organizing pneumonia.

Authors:  E Lappi-Blanco; Y Soini; P Pääkkö
Journal:  Lung       Date:  1999       Impact factor: 2.584

4.  Inhalation exposure systems for the development of rodent models of sulfur mustard-induced pulmonary injury.

Authors:  Waylon M Weber; Dean A Kracko; Mericka R Lehman; Clinton M Irvin; Lee F Blair; Richard K White; Janet M Benson; Gary R Grotendorst; Yung-Sung Cheng; Jacob D McDonald
Journal:  Toxicol Mech Methods       Date:  2010-01       Impact factor: 2.987

5.  Sulfur mustard vapor effects on differentiated human lung cells.

Authors:  Jeanclare Seagrave; Waylon M Weber; Gary R Grotendorst
Journal:  Inhal Toxicol       Date:  2010-09       Impact factor: 2.724

6.  Levels of cytokine in bronchoalveolar lavage (BAL) fluid in patients with pulmonary fibrosis due to sulfur mustard gas inhalation.

Authors:  Ali Emad; Yasaman Emad
Journal:  J Interferon Cytokine Res       Date:  2007-01       Impact factor: 2.607

7.  Treatment with dexamethasone or liposome-encapsuled vitamin E provides beneficial effects after chemical-induced lung injury.

Authors:  Elisabeth Wigenstam; David Rocksén; Barbro Ekstrand-Hammarström; Anders Bucht
Journal:  Inhal Toxicol       Date:  2009-09       Impact factor: 2.724

8.  Compartmentalized expression of c-FLIP in lung tissues of patients with idiopathic pulmonary fibrosis.

Authors:  Seung-Ick Cha; Steve D Groshong; Stephen K Frankel; Ben L Edelman; Gregory P Cosgrove; Jennifer L Terry-Powers; Linda K Remigio; Douglas Curran-Everett; Kevin K Brown; Carlyne D Cool; David W H Riches
Journal:  Am J Respir Cell Mol Biol       Date:  2009-04-16       Impact factor: 6.914

9.  The immunostatus of natural killer cells in people exposed to sulfur mustard.

Authors:  Ladan Ghotbi; Zuhair Hassan
Journal:  Int Immunopharmacol       Date:  2002-06       Impact factor: 4.932

10.  The Th17 pathway in cystic fibrosis lung disease.

Authors:  Hui-Leng Tan; Nicolas Regamey; Sarah Brown; Andrew Bush; Clare M Lloyd; Jane C Davies
Journal:  Am J Respir Crit Care Med       Date:  2011-04-07       Impact factor: 21.405

View more
  9 in total

1.  Mast Cells Promote Nitrogen Mustard-Mediated Toxicity in the Lung Associated With Proinflammatory Cytokine and Bioactive Lipid Mediator Production.

Authors:  Angela Cruz-Hernandez; Ryan P Mendoza; Kathleen Nguyen; Anna Harder; Christopher M Evans; Alison K Bauer; Neera Tewari-Singh; Jared M Brown
Journal:  Toxicol Sci       Date:  2021-10-27       Impact factor: 4.109

2.  Pulmonary injury and oxidative stress in rats induced by inhaled sulfur mustard is ameliorated by anti-tumor necrosis factor-α antibody.

Authors:  Rama Malaviya; Alyssa Bellomo; Elena Abramova; Claire R Croutch; Julie Roseman; Rick Tuttle; Eric Peters; Robert P Casillas; Vasanthi R Sunil; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2021-08-11       Impact factor: 4.460

3.  Attenuation of Nitrogen Mustard-Induced Pulmonary Injury and Fibrosis by Anti-Tumor Necrosis Factor-α Antibody.

Authors:  Rama Malaviya; Vasanthi R Sunil; Alessandro Venosa; Vivianne L Verissimo; Jessica A Cervelli; Kinal N Vayas; LeRoy Hall; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Sci       Date:  2015-08-04       Impact factor: 4.849

Review 4.  Mustard vesicant-induced lung injury: Advances in therapy.

Authors:  Barry Weinberger; Rama Malaviya; Vasanthi R Sunil; Alessandro Venosa; Diane E Heck; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2016-05-19       Impact factor: 4.219

5.  The injury progression of T lymphocytes in a mouse model with subcutaneous injection of a high dose of sulfur mustard.

Authors:  Yi-Zhou Mei; Xiao-Rui Zhang; Ning Jiang; Jun-Ping Cheng; Feng Liu; Pan Zheng; Wen-Xia Zhou; Yong-Xiang Zhang
Journal:  Mil Med Res       Date:  2014-12-19

Review 6.  The systemic nature of mustard lung: Comparison with COPD patients.

Authors:  Alireza Shahriary; Mostafa Ghanei; Hossein Rahmani
Journal:  Interdiscip Toxicol       Date:  2018-02-14

7.  Polydatin ameliorates pulmonary fibrosis by suppressing inflammation and the epithelial mesenchymal transition via inhibiting the TGF-β/Smad signaling pathway.

Authors:  Yue Qiu; Xue Pan; Yahui Hu
Journal:  RSC Adv       Date:  2019-03-12       Impact factor: 3.361

8.  Pathway reconstruction of airway remodeling in chronic lung diseases: a systems biology approach.

Authors:  Ali Najafi; Ali Masoudi-Nejad; Mostafa Ghanei; Mohamad-Reza Nourani; Ali Moeini
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

9.  Characterization of Lung Fibroblasts More than Two Decades after Mustard Gas Exposure.

Authors:  Gila Pirzad Jahromi; Mostafa Ghanei; Seyed Kazem Hosseini; Alireza Shamsaei; Mazaher Gholipourmalekabadi; Ameneh Koochaki; Nushin Karkuki Osguei; Ali Samadikuchaksaraei
Journal:  PLoS One       Date:  2015-12-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.